| Molecule | Cat. No. | Product Name | Host Species | Reactive Species | Applications | Size&Price | Add to Cart |
|---|---|---|---|---|---|---|---|
| HRSV F | Monoclonal Anti-HRSV F Antibody, Human IgG1 (Palivizumab) | Mouse | Virus | $415.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Efmarodocokin alfa | RO-7021610; UTTR-1147A; RG-7880 | Phase 2 Clinical | Genentech Inc | Diabetic Foot; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Colitis, Ulcerative; Crohn Disease | Details |
| Temtokibart | ARGX-112; LEO-138559; LP-0145 | Phase 2 Clinical | Argenx Se, Leo Pharma Inc | Dermatitis, Atopic | Details |
| CK-0045 | CK-0045 | Phase 2 Clinical | Cytoki Pharma ApS | Diabetes Mellitus, Type 2; Obesity; Overweight | Details |
| Eflepedocokin alfa | F-652 | Phase 2 Clinical | Evive Biotech Ltd | Hepatitis, Alcoholic; Pancreatitis; Coronavirus Disease 2019 (COVID-19); Graft vs Host Disease; Acute-On-Chronic Liver Failure | Details |
| ABBV-022 | ABBV-022 | Phase 1 Clinical | Abbvie Inc | Colitis, Ulcerative | Details |